MENU
ATOS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Atossa Therapeutics (ATOS) Ownership - Who owns Atossa Therapeutics?
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology... Show more
Industry: #Medical Specialties
Profile
Industry
Medical Specialties
Address
107 Spring Street
Phone
+1 206 588-0256
Employees
12
Web
https://www.atossatherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
100.3M
P/E Ratio
N/A
Total Cash
65.12M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
2.03
Dividend Yield
N/A
Total Cash/Share
0.50
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ATOS
Capitalization
100M
P/E Ratio
N/A
Risk (Beta)
2.03
Dividend Yield
N/A
Total Cash
65.1M
Total Cash/Share
0.50
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
65.3M
P/B Ratio
1.74
Cash Flow
N/A
Earnings
-0.2
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
23.5M
Current Ratio
12.67
Current Revenue Per Employee
25741.47
Dividends Per Share - Security
N/A
EBITDA
-28.04M
Float
N/A
Float - Current
N/A
Gross Income Margin
59.42
Revenue To Assets
-32.56
Shares Held By Institutions
32.6M
Shares Outstanding - Current
129M
Total Liabilities
5.43M
Total Volume MTD
N/A
Value
1
Gain YTD
-17.752
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ATOS showed earnings on August 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a manufacturer of products for breast cancer
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Medical Specialties
Address
107 Spring Street
Phone
+1 206 588-0256
Employees
12
Web
https://www.atossatherapeutics.com